(Q46610978)

English

Rimonabant: unique and promising

scientific article published in January 2005

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

title

Rimonabant: unique and promising (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

author name string

Ezra A Amsterdam

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

publication date

1 January 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

published in

Preventive Cardiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

page(s)

140

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

cites work

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2005.4013.X

retrieved

21 January 2018

Rimonabant--a selective CB1 antagonist

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2005.4013.X

retrieved

21 January 2018

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2005.4013.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1520-037X.2005.4013.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

PubMed publication ID

16034214

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034214

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034214

(Q46610978)

Rimonabant: unique and promising

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)